Beneficial Effect of Intravenous Taurine Infusion on Electroretinographic Disorder in Taurine Deficient Rats.
スポンサーリンク
概要
- 論文の詳細を見る
We investigated the effect of intravenous taurine infusion on the electroretinogram (ERG) of taurine-deficient rats produced by treatment with guanidinoethyl sulfonate (GES), a taurine transport inhibitor. Mother rats were fed a taurine-free diet and given drinking water containing 1% GES from 2 weeks of gestation to weaning. The same feeding conditions were applied to male offspring after weaning. Both ERG measurement and continuous infusion of taurine at a dose of 10, 30 or 100 mg/animal/day were performed for 3 weeks from 7 to 10 weeks of age. GES-treatment reduced a- and b-wave amplitudes to 50% of the control levels and also increased b-wave latencies. Intravenous infusion of taurine improved these ERG abnormalities in a dose-dependent manner. Taurine concentrations in plasma, eyes and brain were also decreased by treatment with GES, and dose-dependent recovery was observed after infusion with taurine, although the concentrations of other amino acids were not affected by GES-treatment and infusion of taurine. Observations of morphological changes revealed that the retinal damage in GES-treated animals was decreased by taurine infusion. These results indicate that the changes in ERG and retinal structure observed in taurine deficiency are improved by intravenous infusion of taurine.
- 公益社団法人 日本薬理学会の論文
著者
-
Shimada Chiaki
Research And Development Center Fuso Pharmaceutical Industries Ltd.
-
Kuroda Sumio
Research and Development Center, Fuso Pharmaceutical Industries, Ltd.
-
Tanaka Shuichi
Research and Development Center, Fuso Pharmaceutical Industries, Ltd.
-
Hasegawa Michinori
Research and Development Center, Fuso Pharmaceutical Industries, Ltd.
-
Isaka Kiyotsugu
Research and Development Center, Fuso Pharmaceutical Industries, Ltd.
-
Sano Mitsuo
Research and Development Center, Fuso Pharmaceutical Industries, Ltd.
-
Araki Hiromasa
Research and Development Center, Fuso Pharmaceutical Industries, Ltd.
関連論文
- QT PRODACT : Evaluation of the Potential of Compounds to Cause QT Interval Prolongation by Action Potential Assays Using Guinea-Pig Papillary Muscles
- QT PRODACT : Inter- and Intra-facility Variability of the Action Potential Assay Using Isolated Guinea-Pig Papillary Muscles
- QT PRODACT : A Multi-site Study of In Vitro Action Potential Assays on 21 Compounds in Isolated Guinea-Pig Papillary Muscles
- P8-07 QT Interval Prolongation : Project for Database Construction, 1) Standard Protocol, and Inter- and Intra-Facility Differences in APD Assay Using Isolated Guinea Pig Papillary Muscles(CIRCULATORY SYSTEM-2/ACTIVE OXYGEN)(GENERAL SESSION BY POSTER PRES
- P8-03 In vitro action potential duration assay for assessing the potential for QT interval prolongation : Effects of bepridil on action potentials in guinea-pig papillary muscles(CIRCULATORY SYSTEM-2/ACTIVE OXYGEN)(GENERAL SESSION BY POSTER PRESENTATION)(
- Beneficial Effect of Intravenous Taurine Infusion on Electroretinographic Disorder in Taurine Deficient Rats.